Clinical trial reveals genetic fault that reduces the effectiveness of leukaemia treatment

A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment. The findings come from a clinical trial led by the University of Birmingham that examined whether survival times for people with acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) could be improved … Continue reading “Clinical trial reveals genetic fault that reduces the effectiveness of leukaemia treatment”

Ministerial announcement provides funding boost

Following the Secretary of State for Health the Rt. Hon. Jeremy Hunt’s announcement of £14.25m funding to support 11 NIHR medtech and in vitro diagnostic cooperatives nationally, we are delighted to announce that University Hospitals Birmingham NHS Foundation Trust (UHB) has been awarded funding to establish the NIHR Trauma Management MedTech Cooperative (MTC). The cooperatives will … Continue reading “Ministerial announcement provides funding boost”